Please login to the form below
NanoValent promotes Mark Lewis to COO
He will also continue to manage the group’s business operations
UK and US-based NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer.
Lewis brings over 30 years of international commercial and operations expertise - gained primarily in the area of oncology - to the role, and first joined the early-stage oncology group in 2015.
He has worked at a number of pharmaceutical firms including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer).
In addition to his pharmaceutical experience, Lewis also spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles.
Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc from 2010 until 2012.
Featured jobs
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Associate Scientific Director
-
Salary TBC
-
Systematic Review Lead- London
-
Negotiable
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Senior Medical Writer
-
Salary is DOE
-
Account Manager
-
Negotiable
Subscribe to our email news alerts
- Bluebird’s first gene therapy gets European fast track
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- J&J files ‘breakthrough’ bladder cancer drug in US
- Moving annual total (MAT)
- After Lucentis setback, Novartis trumpets data on follow-up drug
- Amarin hits jackpot with astonishing heart benefits from fish oil product
- Novartis cuts manufacturing jobs in Switzerland and UK
- New Awards scheme for medical and scientific professionals
- Random42 Exhibiting at BioCap Conference 2018
- Bedrock scoops top prizes at Digital Awards
- After Lucentis setback, Novartis trumpets data on follow-up drug
PMHub
Apex.co.uk Conferences, Events and Exhibition Stands
Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...
Latest intelligence
- Solaris Health looks at the gene therapy revolution
- Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
Quick links
Infographics
